Imaging agents are designed to provide more information about internal organs, cellular processes and tumors, as well as normal tissue. They can be used to diagnose disease as well as monitor treatment effects.
Molecular imaging agents are small molecules, peptides, engineered proteins, aptamers and nanoparticles. The main purpose of a molecular imaging agent is to cross-examine and report back about a specific target of interest during the course of a molecular imaging study. Typically a molecular imaging agent comprises of a targeting component and a signaling component.
A molecular imaging agent is designed to specifically interact with one or more molecular targets, which need to be first introduced to study biochemical processes. Imaging agents also have a long list of alternative names including probes, imaging probes, agents, molecular spies, molecular beacons, molecular detectives, radiopharmaceuticals, radiolabeled probes, and tracers. A molecular imaging agent should have the following characteristics: high selectivity for biochemical target, good in vivo stability, cost and time effective synthesis, good ratio of specific to non-specific binding, signal amplification, good safety profile and multiplexing capabilities.
In 2019, the market size of Imaging Agents is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Imaging Agents.
This report studies the global market size of Imaging Agents, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Imaging Agents production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Bayer Healthcare Pharmaceuticals
Bracco Diagnostics
Daiichi Sankyo
Eisai
Eli Lilly and Company
EUSA Pharma
GE Healthcare
Guerbet Group
Lantheus Medical Imaging
Mallinckrodt Pharmaceuticals
Shenzhen Xingjingwei
Beijing Chemical Reagent Research Institute
Lanxing Chemial Materials
Baoding Lucky Chemical
Market Segment by Product Type
Oncology
Cardiology
Gastrointestinal Disorders
Neurology Disorders
Market Segment by Application
Hospitals & Clinics
Ambulatory Surgical Centers
Diagnostic & imaging centers
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Imaging Agents status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Imaging Agents manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Imaging Agents are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Molecular imaging agents are small molecules, peptides, engineered proteins, aptamers and nanoparticles. The main purpose of a molecular imaging agent is to cross-examine and report back about a specific target of interest during the course of a molecular imaging study. Typically a molecular imaging agent comprises of a targeting component and a signaling component.
A molecular imaging agent is designed to specifically interact with one or more molecular targets, which need to be first introduced to study biochemical processes. Imaging agents also have a long list of alternative names including probes, imaging probes, agents, molecular spies, molecular beacons, molecular detectives, radiopharmaceuticals, radiolabeled probes, and tracers. A molecular imaging agent should have the following characteristics: high selectivity for biochemical target, good in vivo stability, cost and time effective synthesis, good ratio of specific to non-specific binding, signal amplification, good safety profile and multiplexing capabilities.
In 2019, the market size of Imaging Agents is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Imaging Agents.
This report studies the global market size of Imaging Agents, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Imaging Agents production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Bayer Healthcare Pharmaceuticals
Bracco Diagnostics
Daiichi Sankyo
Eisai
Eli Lilly and Company
EUSA Pharma
GE Healthcare
Guerbet Group
Lantheus Medical Imaging
Mallinckrodt Pharmaceuticals
Shenzhen Xingjingwei
Beijing Chemical Reagent Research Institute
Lanxing Chemial Materials
Baoding Lucky Chemical
Market Segment by Product Type
Oncology
Cardiology
Gastrointestinal Disorders
Neurology Disorders
Market Segment by Application
Hospitals & Clinics
Ambulatory Surgical Centers
Diagnostic & imaging centers
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Imaging Agents status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Imaging Agents manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Imaging Agents are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Imaging Agents Market Size Growth Rate by Type (2019-2025)
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Gastrointestinal Disorders
1.3.5 Neurology Disorders
1.4 Market Segment by Application
1.4.1 Global Imaging Agents Market Share by Application (2019-2025)
1.4.2 Hospitals & Clinics
1.4.3 Ambulatory Surgical Centers
1.4.4 Diagnostic & imaging centers
1.4.5 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Imaging Agents Production Value 2014-2025
2.1.2 Global Imaging Agents Production 2014-2025
2.1.3 Global Imaging Agents Capacity 2014-2025
2.1.4 Global Imaging Agents Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2019-2025
2.2.1 Global Imaging Agents Market Size CAGR of Key Regions
2.2.2 Global Imaging Agents Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Imaging Agents Capacity by Manufacturers
3.1.2 Global Imaging Agents Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Imaging Agents Revenue by Manufacturers (2014-2019)
3.2.2 Imaging Agents Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Imaging Agents Market Concentration Ratio (CR5 and HHI)
3.3 Imaging Agents Price by Manufacturers
3.4 Key Manufacturers Imaging Agents Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Imaging Agents Market
3.6 Key Manufacturers Imaging Agents Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 Oncology Production and Production Value (2014-2019)
4.1.2 Cardiology Production and Production Value (2014-2019)
4.1.3 Gastrointestinal Disorders Production and Production Value (2014-2019)
4.1.4 Neurology Disorders Production and Production Value (2014-2019)
4.2 Global Imaging Agents Production Market Share by Type
4.3 Global Imaging Agents Production Value Market Share by Type
4.4 Imaging Agents Ex-factory Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Imaging Agents Consumption by Application
6 Production by Regions
6.1 Global Imaging Agents Production (History Data) by Regions 2014-2019
6.2 Global Imaging Agents Production Value (History Data) by Regions
6.3 United States
6.3.1 United States Imaging Agents Production Growth Rate 2014-2019
6.3.2 United States Imaging Agents Production Value Growth Rate 2014-2019
6.3.3 Key Players in United States
6.3.4 United States Imaging Agents Import & Export
6.4 European Union
6.4.1 European Union Imaging Agents Production Growth Rate 2014-2019
6.4.2 European Union Imaging Agents Production Value Growth Rate 2014-2019
6.4.3 Key Players in European Union
6.4.4 European Union Imaging Agents Import & Export
6.5 China
6.5.1 China Imaging Agents Production Growth Rate 2014-2019
6.5.2 China Imaging Agents Production Value Growth Rate 2014-2019
6.5.3 Key Players in China
6.5.4 China Imaging Agents Import & Export
6.6 Rest of World
6.6.1 Japan
6.6.2 Korea
6.6.3 India
6.6.4 Southeast Asia
7 Imaging Agents Consumption by Regions
7.1 Global Imaging Agents Consumption (History Data) by Regions
7.2 United States
7.2.1 United States Imaging Agents Consumption by Type
7.2.2 United States Imaging Agents Consumption by Application
7.3 European Union
7.3.1 European Union Imaging Agents Consumption by Type
7.3.2 European Union Imaging Agents Consumption by Application
7.4 China
7.4.1 China Imaging Agents Consumption by Type
7.4.2 China Imaging Agents Consumption by Application
7.5 Rest of World
7.5.1 Rest of World Imaging Agents Consumption by Type
7.5.2 Rest of World Imaging Agents Consumption by Application
7.5.1 Japan
7.5.2 Korea
7.5.3 India
7.5.4 Southeast Asia
8 Company Profiles
8.1 Bayer Healthcare Pharmaceuticals
8.1.1 Bayer Healthcare Pharmaceuticals Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Imaging Agents
8.1.4 Imaging Agents Product Introduction
8.1.5 Bayer Healthcare Pharmaceuticals Recent Development
8.2 Bracco Diagnostics
8.2.1 Bracco Diagnostics Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Imaging Agents
8.2.4 Imaging Agents Product Introduction
8.2.5 Bracco Diagnostics Recent Development
8.3 Daiichi Sankyo
8.3.1 Daiichi Sankyo Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Imaging Agents
8.3.4 Imaging Agents Product Introduction
8.3.5 Daiichi Sankyo Recent Development
8.4 Eisai
8.4.1 Eisai Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Imaging Agents
8.4.4 Imaging Agents Product Introduction
8.4.5 Eisai Recent Development
8.5 Eli Lilly and Company
8.5.1 Eli Lilly and Company Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of Imaging Agents
8.5.4 Imaging Agents Product Introduction
8.5.5 Eli Lilly and Company Recent Development
8.6 EUSA Pharma
8.6.1 EUSA Pharma Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of Imaging Agents
8.6.4 Imaging Agents Product Introduction
8.6.5 EUSA Pharma Recent Development
8.7 GE Healthcare
8.7.1 GE Healthcare Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of Imaging Agents
8.7.4 Imaging Agents Product Introduction
8.7.5 GE Healthcare Recent Development
8.8 Guerbet Group
8.8.1 Guerbet Group Company Details
8.8.2 Company Description and Business Overview
8.8.3 Production and Revenue of Imaging Agents
8.8.4 Imaging Agents Product Introduction
8.8.5 Guerbet Group Recent Development
8.9 Lantheus Medical Imaging
8.9.1 Lantheus Medical Imaging Company Details
8.9.2 Company Description and Business Overview
8.9.3 Production and Revenue of Imaging Agents
8.9.4 Imaging Agents Product Introduction
8.9.5 Lantheus Medical Imaging Recent Development
8.10 Mallinckrodt Pharmaceuticals
8.10.1 Mallinckrodt Pharmaceuticals Company Details
8.10.2 Company Description and Business Overview
8.10.3 Production and Revenue of Imaging Agents
8.10.4 Imaging Agents Product Introduction
8.10.5 Mallinckrodt Pharmaceuticals Recent Development
8.11 Shenzhen Xingjingwei
8.12 Beijing Chemical Reagent Research Institute
8.13 Lanxing Chemial Materials
8.14 Baoding Lucky Chemical
9 Market Forecast
9.1 Global Market Size Forecast
9.1.1 Global Imaging Agents Capacity, Production Forecast 2019-2025
9.1.2 Global Imaging Agents Production Value Forecast 2019-2025
9.2 Market Forecast by Regions
9.2.1 Global Imaging Agents Production and Value Forecast by Regions 2019-2025
9.2.2 Global Imaging Agents Consumption Forecast by Regions 2019-2025
9.3 United States
9.3.1 Production and Value Forecast in United States
9.3.2 Consumption Forecast in United States
9.4 European Union
9.4.1 Production and Value Forecast in European Union
9.4.2 Consumption Forecast in European Union
9.5 China
9.5.1 Production and Value Forecast in China
9.5.2 Consumption Forecast in China
9.6 Rest of World
9.6.1 Japan
9.6.2 Korea
9.6.3 India
9.6.4 Southeast Asia
9.7 Forecast by Type
9.7.1 Global Imaging Agents Production Forecast by Type
9.7.2 Global Imaging Agents Production Value Forecast by Type
9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
10.1 Value Chain Analysis
10.2 Sales Channels Analysis
10.2.1 Imaging Agents Sales Channels
10.2.2 Imaging Agents Distributors
10.3 Imaging Agents Customers
11 Opportunities & Challenges, Threat and Affecting Factors
11.1 Market Opportunities
11.2 Market Challenges
11.3 Porter''s Five Forces Analysis
12 Key Findings
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Imaging Agents Market Size Growth Rate by Type (2019-2025)
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Gastrointestinal Disorders
1.3.5 Neurology Disorders
1.4 Market Segment by Application
1.4.1 Global Imaging Agents Market Share by Application (2019-2025)
1.4.2 Hospitals & Clinics
1.4.3 Ambulatory Surgical Centers
1.4.4 Diagnostic & imaging centers
1.4.5 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Imaging Agents Production Value 2014-2025
2.1.2 Global Imaging Agents Production 2014-2025
2.1.3 Global Imaging Agents Capacity 2014-2025
2.1.4 Global Imaging Agents Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2019-2025
2.2.1 Global Imaging Agents Market Size CAGR of Key Regions
2.2.2 Global Imaging Agents Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Imaging Agents Capacity by Manufacturers
3.1.2 Global Imaging Agents Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Imaging Agents Revenue by Manufacturers (2014-2019)
3.2.2 Imaging Agents Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Imaging Agents Market Concentration Ratio (CR5 and HHI)
3.3 Imaging Agents Price by Manufacturers
3.4 Key Manufacturers Imaging Agents Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Imaging Agents Market
3.6 Key Manufacturers Imaging Agents Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 Oncology Production and Production Value (2014-2019)
4.1.2 Cardiology Production and Production Value (2014-2019)
4.1.3 Gastrointestinal Disorders Production and Production Value (2014-2019)
4.1.4 Neurology Disorders Production and Production Value (2014-2019)
4.2 Global Imaging Agents Production Market Share by Type
4.3 Global Imaging Agents Production Value Market Share by Type
4.4 Imaging Agents Ex-factory Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Imaging Agents Consumption by Application
6 Production by Regions
6.1 Global Imaging Agents Production (History Data) by Regions 2014-2019
6.2 Global Imaging Agents Production Value (History Data) by Regions
6.3 United States
6.3.1 United States Imaging Agents Production Growth Rate 2014-2019
6.3.2 United States Imaging Agents Production Value Growth Rate 2014-2019
6.3.3 Key Players in United States
6.3.4 United States Imaging Agents Import & Export
6.4 European Union
6.4.1 European Union Imaging Agents Production Growth Rate 2014-2019
6.4.2 European Union Imaging Agents Production Value Growth Rate 2014-2019
6.4.3 Key Players in European Union
6.4.4 European Union Imaging Agents Import & Export
6.5 China
6.5.1 China Imaging Agents Production Growth Rate 2014-2019
6.5.2 China Imaging Agents Production Value Growth Rate 2014-2019
6.5.3 Key Players in China
6.5.4 China Imaging Agents Import & Export
6.6 Rest of World
6.6.1 Japan
6.6.2 Korea
6.6.3 India
6.6.4 Southeast Asia
7 Imaging Agents Consumption by Regions
7.1 Global Imaging Agents Consumption (History Data) by Regions
7.2 United States
7.2.1 United States Imaging Agents Consumption by Type
7.2.2 United States Imaging Agents Consumption by Application
7.3 European Union
7.3.1 European Union Imaging Agents Consumption by Type
7.3.2 European Union Imaging Agents Consumption by Application
7.4 China
7.4.1 China Imaging Agents Consumption by Type
7.4.2 China Imaging Agents Consumption by Application
7.5 Rest of World
7.5.1 Rest of World Imaging Agents Consumption by Type
7.5.2 Rest of World Imaging Agents Consumption by Application
7.5.1 Japan
7.5.2 Korea
7.5.3 India
7.5.4 Southeast Asia
8 Company Profiles
8.1 Bayer Healthcare Pharmaceuticals
8.1.1 Bayer Healthcare Pharmaceuticals Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Imaging Agents
8.1.4 Imaging Agents Product Introduction
8.1.5 Bayer Healthcare Pharmaceuticals Recent Development
8.2 Bracco Diagnostics
8.2.1 Bracco Diagnostics Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Imaging Agents
8.2.4 Imaging Agents Product Introduction
8.2.5 Bracco Diagnostics Recent Development
8.3 Daiichi Sankyo
8.3.1 Daiichi Sankyo Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Imaging Agents
8.3.4 Imaging Agents Product Introduction
8.3.5 Daiichi Sankyo Recent Development
8.4 Eisai
8.4.1 Eisai Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Imaging Agents
8.4.4 Imaging Agents Product Introduction
8.4.5 Eisai Recent Development
8.5 Eli Lilly and Company
8.5.1 Eli Lilly and Company Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of Imaging Agents
8.5.4 Imaging Agents Product Introduction
8.5.5 Eli Lilly and Company Recent Development
8.6 EUSA Pharma
8.6.1 EUSA Pharma Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of Imaging Agents
8.6.4 Imaging Agents Product Introduction
8.6.5 EUSA Pharma Recent Development
8.7 GE Healthcare
8.7.1 GE Healthcare Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of Imaging Agents
8.7.4 Imaging Agents Product Introduction
8.7.5 GE Healthcare Recent Development
8.8 Guerbet Group
8.8.1 Guerbet Group Company Details
8.8.2 Company Description and Business Overview
8.8.3 Production and Revenue of Imaging Agents
8.8.4 Imaging Agents Product Introduction
8.8.5 Guerbet Group Recent Development
8.9 Lantheus Medical Imaging
8.9.1 Lantheus Medical Imaging Company Details
8.9.2 Company Description and Business Overview
8.9.3 Production and Revenue of Imaging Agents
8.9.4 Imaging Agents Product Introduction
8.9.5 Lantheus Medical Imaging Recent Development
8.10 Mallinckrodt Pharmaceuticals
8.10.1 Mallinckrodt Pharmaceuticals Company Details
8.10.2 Company Description and Business Overview
8.10.3 Production and Revenue of Imaging Agents
8.10.4 Imaging Agents Product Introduction
8.10.5 Mallinckrodt Pharmaceuticals Recent Development
8.11 Shenzhen Xingjingwei
8.12 Beijing Chemical Reagent Research Institute
8.13 Lanxing Chemial Materials
8.14 Baoding Lucky Chemical
9 Market Forecast
9.1 Global Market Size Forecast
9.1.1 Global Imaging Agents Capacity, Production Forecast 2019-2025
9.1.2 Global Imaging Agents Production Value Forecast 2019-2025
9.2 Market Forecast by Regions
9.2.1 Global Imaging Agents Production and Value Forecast by Regions 2019-2025
9.2.2 Global Imaging Agents Consumption Forecast by Regions 2019-2025
9.3 United States
9.3.1 Production and Value Forecast in United States
9.3.2 Consumption Forecast in United States
9.4 European Union
9.4.1 Production and Value Forecast in European Union
9.4.2 Consumption Forecast in European Union
9.5 China
9.5.1 Production and Value Forecast in China
9.5.2 Consumption Forecast in China
9.6 Rest of World
9.6.1 Japan
9.6.2 Korea
9.6.3 India
9.6.4 Southeast Asia
9.7 Forecast by Type
9.7.1 Global Imaging Agents Production Forecast by Type
9.7.2 Global Imaging Agents Production Value Forecast by Type
9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
10.1 Value Chain Analysis
10.2 Sales Channels Analysis
10.2.1 Imaging Agents Sales Channels
10.2.2 Imaging Agents Distributors
10.3 Imaging Agents Customers
11 Opportunities & Challenges, Threat and Affecting Factors
11.1 Market Opportunities
11.2 Market Challenges
11.3 Porter''s Five Forces Analysis
12 Key Findings
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
